Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.90
+0.15003.16%
Volume:329.30K
Turnover:1.60M
Market Cap:334.83M
PE:-2.22
High:4.99
Open:4.82
Low:4.72
Close:4.75
Loading ...
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 17, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 14, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]